↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$113KSold on the market
1Companies
Sep 29, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 202621:12 | Sep 25, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $36.57 | −3,097 | 359,036 | -1% | −$113K | ||
| Sep 14, 202608:30 | Sep 14, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Commercial Officer | A · Grant | — | +125,000 | 362,133 | +53% | — | ||
| Aug 12, 202608:30 | Aug 12, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Commercial Officer | A · Grant | — | +62,500 | 237,133 | +36% | — |